Ibuprofen undermines aspirin's heart effects

June 2005
Consumer Reports on Health;Jun2005, Vol. 17 Issue 6, p10
Discusses the potential of ibuprofen and other over-the-counter options to counteract the ability of aspirin to resist heart attack and stroke. Role of aspirin in protecting the heart and brain; Risk factors for cardiovascular disease; Efficacy of the drugs.


Related Articles

  • Imperfect match.  // Bulletin with Newsweek;3/4/2003, Vol. 121 Issue 6362, p45 

    Reports that people who take aspirin to reduce the risk of heart disease need to avoid taking the painkiller ibuprofen. Ibuprofen's ability to block aspirin's anti-clotting effects; Result of analysis of death rates in several heart patients; Weaknesses in design of the study published in the...

  • PREVALENCE AND THE RISK FACTORS FOR ASPIRIN RESISTANCE IN A POPULATION-BASED STUDY OF PATIENTS WITH ACUTE VASCULAR EVENTS. Coull, A. J.; Silver, L. E.; Harrison, P.; Segal, H.; Rothwell, P. M. // Age & Ageing;May2004 Supplement 1, Vol. 33, pi41 

    Presents an abstract of the study "Prevalence and the Risk Factors for Aspirin Resistance in a Population-Based Study of Patients With Acute Vascular Events," by A. J. Coull, L. E. Silver, P. Harrison, H. Segal and P. M. Rothwell.

  • Aspirin resistance is common.  // Cortlandt Forum;Apr2007, Vol. 20 Issue 4, p16 

    The article reports that daily aspirin intake against stroke or myocardial infarction (MI) establishes resistance that would stop the prevention of platelet aggregation. The information was derived from 19 clinical trials participated by 2,700 patients who consumed aspirin dosages from 75...

  • ASCOT study will revolutionise care.  // Practice Nurse;9/23/2005, Vol. 30 Issue 5, p8 

    Reports on the plan to change the treatment of hypertension in nurse-led cardiovascular clinics following the publication of a research on the effectiveness of amlodipine and perindopril in reducing the risks of heart attack and stroke conducted by the Anglo-Scandinavian Cardiac Outcomes Trial...

  • Should women take it?  // Consumer Reports on Health;Jun2005, Vol. 17 Issue 6, p10 

    Focuses on the clinical trial on the use of aspirin to prevent heart attacks in older women in the U.S. Risk factors of heart attack and stroke; Percentage of women with greater risk for strokes; Efficacy of aspirin.

  • Current Issues.  // PharmacoEconomics & Outcomes News;4/4/2009, Issue 575, p2 

    The article reports on the recommendation by the U.S. Preventive Services Task Force that patients and clinicians consider risk factors before deciding to use aspirin for prophylaxis against myocardial infarction or strokes. Age, gender and cholesterol levels are some of the risk factors that...

  • Aspirin and Risk of Hemorrhagic Stroke. He, Jiang; Whelton, Paul K.; Vu, Brian; Klag, Michael J. // JAMA: Journal of the American Medical Association;12/9/98, Vol. 280 Issue 22, p1930 

    Considers how aspirin has been widely used to prevent myocardial infarction in ischemic stroke, though some studies have suggested it increases the risk of hemorrhagic stroke. Study to estimate the risk of hemorrhagic stroke associated with aspirin treatment; Data sources; Study selection; Data...

  • OTC Update. Feferman, Irv // Ontario Dentist;Mar2008, Vol. 85 Issue 2, p14 

    The article presents an update on over-the-counter medications. The positive effect of acetylsalicylic acid on lowering the risk of stroke in women and myocardial infarction in men has been proven. No studies have yet proven the medical benefits of fish oil supplements. Glucosamine and...

  • Aspirin to Prevent Cardiovascular Disease: The Association of Aspirin Dose and Clopidogrel With Thrombosis and Bleeding. Steinhubl, Steven R.; Bhatt, Deepak L.; Brennan, Danielle M.; Montalescot, Gilles; Hankey, Graeme J.; Eikelboom, John W.; Berger, Peter B.; Topol, Eric J. // Annals of Internal Medicine;3/17/2009, Vol. 150 Issue 6, p379 

    Background: The optimal aspirin dose for the prevention of cardiovascular events remains controversial. Objective: To assess the incidence of and risk factors for adverse clinical outcomes by investigator-determined aspirin dose in a primary prevention trial. Design: Post hoc observational...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics